Rafael Holdings

0 followers

‌

Rafael Holdings (NYSE: RFL) is focused on the development of novel cancer therapies. The Company is a significant investor in two clinical stage oncology companies-- Rafael Pharmaceuticals, Inc. and LipoMedix Pharmaceuticals Ltd.

Industries

Headquarters

Employees

Links

Org chart

William Conkling

CEO

William Conkling

Collapse

David Polinsky

Chief Financial Officer

Ari Landon

Director Of Innovation

Teams

Management

8 members

Similar companies

Day One Biopharmaceuticals

1 follower

PMV Pharmaceuticals

1 follower

Applied Therapeutics

1 follower

Anthos Therapeutics

1 follower

Astria Therapeutics

1 follower

Thermo Fisher Scientific

141 followers

Genentech

143 followers

Regeneron

87 followers

ADARx Pharmaceuticals

2 followers

Alexion Pharmaceuticals

32 followers

Ionis Pharmaceuticals

22 followers

Discover companies